Skip to main content
Top
Published in: Reactions Weekly 1/2023

01-01-2023 | Joint Pain | Case report

Multiple drugs

Increased level of tacrolimus following interaction between tacrolimus and voriconazole and lack of efficacy: case report

Published in: Reactions Weekly | Issue 1/2023

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:Drug interaction
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Hiraoka D, et al. A case of clinically amyopathic dermatomyositis that was refractory to intensive immunosuppressive therapy including tofacitinib, but successfully treated with plasma exchange therapy. Modern Rheumatology Case Reports 6: 194-198, No. 2, 24 Jun 2022. Available from: URL: http://doi.org/10.1093/mrcr/rxab054 Hiraoka D, et al. A case of clinically amyopathic dermatomyositis that was refractory to intensive immunosuppressive therapy including tofacitinib, but successfully treated with plasma exchange therapy. Modern Rheumatology Case Reports 6: 194-198, No. 2, 24 Jun 2022. Available from: URL: http://​doi.​org/​10.​1093/​mrcr/​rxab054
Metadata
Title
Multiple drugs
Increased level of tacrolimus following interaction between tacrolimus and voriconazole and lack of efficacy: case report
Publication date
01-01-2023
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-31038-7

Other articles of this Issue 1/2023

Reactions Weekly 1/2023 Go to the issue

Case report

Propofol

Case report

Prednisolone

Case report

Multiple drugs

Case report

Ingenol-mebutate

Case report

Multiple drugs